refresher course in ophthalmology

Fernandez-Vega Institute will present its third professionals engaged in the research phase for a refresher course in ophthalmology.

Prestigious ophthalmologists attend this conference to be held on 8 and 9 May. Know the new facilities and will make a major update on solutions to major eye diseases.

Following the recent opening of the third institutional phase Fernández-Vega Ophthalmological Institute by Their Majesties King, the center will host the next days 8 and 9 May, a Refresher Course in Ophthalmology, congress will present to the ophthalmologists new facilities dedicated to basic research. The meeting, which will serve its audience to catch up on the major advances achieved in recent years in all or almost all ophthalmic disciplines, will also address important issues that already begun research in the center, including new techniques and treatment of glaucoma and other diseases common in the cornea and retina.

The course, attended by two hundred experts from around the world, is led by Professor Luis Fernández-Vega Sanz, director of the Eye Institute, and is divided into the following six sessions (led by doctors at each of them are listed ) Supeficie eye (doctors and Begoña Baamonde Jesus Merayo Arbaiza) Cornea and refractive (José F. Alfonso Sanchez and Mariano Sanchez Yllera), Cataract (Luis Fernández-Vega Sanz and Jose I. Blázquez García), Orbit and appendages (Javier Fernandez -Vega Sanz), Glaucoma (Pedro Pablo Martín and Manuel Calvo Riano Granero) and Retina (Álvaro Fernández-Vega Sanz).

Institute director, Luis Fernández-Vega Sanz, considered appropriate that the opening of the third phase had not only some institutional (or social) but held a medical activity that would serve, in turn, to present to the world of Medicine is pioneering basic research unit in Europe in which they have invested six million euros and which employs more than twenty internationally renowned specialists.



Six working sessions

The first session (Supeficie eye) will try to update the most common problems of the ocular surface, such as dry eye or ocular allergies, which cause discomfort (feeling of sand, stinging, itching) and can reduce vision and affect the quality of life of patients and more rare diseases such as ocular manifestations of systemic diseases such as rheumatic or immunological. It will review the prevention, medical and surgical treatment and regenerative medicine will address the ocular surface with the update of transplantation techniques and reconstruction of the cornea, eyelids and conjunctiva.

The second (Cornea and Refractive) address laser surgical techniques and intraocular lenses. On the latter must be said that existing lenses that correct presbyopia and any other defect of graduation. Of them should also highlight that ICLs phakic lenses and can correct most refractive errors: myopia, hipermetromía, astigmatism, etc.. Previously, only solved the first. It is indicated for patients unable to tolerate the laser.

The third meeting (Waterfall), will display new bifocals will present Luis Fernández-Vega Sanz. These lenses improvements to existing ones because they produce better intermediate vision. Also present at this meeting lenses (IOLs) with adjustable light.

The fourth session (Orbit and appendages) will focus on major developments on practical techniques in Ocular Plastic Surgery. Keep in mind that cosmetic surgery that is practiced today in most Western countries are related in a direct way with the eyes, especially the eyelids, orbits and tear ducts.


About Glaucoma (fifth session) will be discussed in depth on the new tools for early diagnosis of the disease (one of the main works to be carried out in the basic research unit of the Institute). It will also address new and better surgical techniques and implants perforating sclerectomy not valvular in glaucoma treatment.



In the last session (Retina) will discuss the progress made in recent years to resolve the macular degeneration associated with age, which is the leading cause of blindness in people over 60 years, which affects, from this age to 7% of world population.